Table 1.
BCC model | Mode of BCC induction | Treatment | Reference |
---|---|---|---|
Pt ch neo12/+ | UV | Cyclopamine | [60] |
Pt ch neo12/+ skin punches | UV | CUR61414 | [61] |
Pt ch neo12/+ | UV | α-difluoromethylornithine | [62] |
Pt ch neo12/+ | IR/UV | Tazarotene | [55] |
Pt ch neo12/+ | UV | Tazarotene, ATRA, AGN195813, AGN194204, AGN194310 | [63] |
Pt ch neo12/+ | IR/UV | Celecoxib, sulindac, MF-tricyclic | [64] |
Pt ch neo12/+ | UV | Green/black tea | [54] |
Pt ch neo12/+ K14-Cre-ER p53fl/fl | IR and conditional p53 ablation | CUR61414 | [65] |
Pt ch neo12/+ K14-Cre-ER p53fl/fl | IR and conditional p53 ablation | Itraconazole | [66] |
Pt ch neo12/+ K14-Cre-ER p53fl/fl | IR and conditional p53 ablation | Vitamin D3 | [67] |
Pt ch flox/flox ER T2+/− | conditional Ptch ablation | Calcitriol | [68] |
UV: ultraviolet radiation; IR: ionizing radiation.